The distinct effects of cytokines on cellular growth and differentiation suggest that specific signaling pathways mediate these diverse biological activities. Fibroblast growth factors (FGFs) are well-established inhibitors of skeletal muscle differentiation and may operate via activation of specific signaling pathways distinct from recently identified mitogen signaling pathways. We examined whether platelet-derived growth factor (PDGF)-activated signaling pathways are sufficient to mediate FGF-dependent repression of myogenesis by introducing the PDGF  receptor into a mouse skeletal muscle cell line. Addition of PDGF-BB to cells expressing the PDGF  receptor activated the PDGF  receptor tyrosine kinase, stimulated mitogen-activated protein (MAP) kinase, and increased the steady-state levels of junB and c-fos mRNAs. Despite the activation of these intracellular signaling molecules, PDGF  receptor activation elicited no detectable effect on cell proliferation or differentiation. In contrast to PDGF-BB, addition of FGF-2 to myoblasts activated signaling pathways that resulted in DNA synthesis and repression of differentiation. Because of the low number of endogenous FGF receptors expressed, FGF-stimulated signaling events, including tyrosine phosphorylation and activation of MAP kinase, could be detected only in cells expressing higher levels of a transfected FGF receptor cDNA. As the PDGF  receptor-and FGF receptor-stimulated signaling pathways yield different biological responses in these skeletal muscle cells, we hypothesize that FGF-mediated repression of skeletal muscle differentiation activates signaling pathways distinct from those activated by the PDGF  receptor. Activation of PDGF  receptor tyrosine kinase activity, stimulation of MAP kinase, and upregulation of immediate-early gene expression are not sufficient to repress skeletal muscle differentiation. Intracellular signaling cascades initiated by growth factor binding to cell surface tyrosine kinase receptors transmit signals that control cell proliferation, differentiation, cell migration, and cell fate. We are examining the fibroblast growth factor (FGF)-mediated signaling pathways that control proliferation and differentiation of skeletal muscle cells. The effects of FGF on both skeletal muscle cell proliferation and differentiation have been well documented in studies using cell lines (40) and primary cell cultures (1,46,53).A satellite cell line (MM14) derived from an adult mouse muscle exhibits an absolute dependence on exogenously supplied FGFs (12, 34). Removal of FGF from the culture medium results in terminal differentiation, which initiates with an irreversible withdrawal from the cell cycle, is followed by expression of muscle-specific genes and culminates with fusion into multinucleated myotubes. The biological activity of FGFs on these cells requires an interaction with heparan sulfate proteoglycans (HSPGs) (43,48). HSPGs have been proposed to form a high-affinity FGF-binding and signaling complex with the FGF receptor tyrosine ki...